2014
DOI: 10.1093/annonc/mdu334.128
|View full text |Cite
|
Sign up to set email alerts
|

An International Observational Study to Assess the Use of Sorafenib After Transarterial Chemoembolization (Tace) in Patients with Hepatocellular Carcinoma (Hcc): Optimis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…To overcome this limitation, a large prospective study is needed. The OPTIMIS study, which is currently underway worldwide, and a large multicenter observational study on TACE could give further answers to our question . Another limitation is that we could not evaluate the influence of the etiology of background liver disease.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…To overcome this limitation, a large prospective study is needed. The OPTIMIS study, which is currently underway worldwide, and a large multicenter observational study on TACE could give further answers to our question . Another limitation is that we could not evaluate the influence of the etiology of background liver disease.…”
Section: Discussionmentioning
confidence: 98%
“…The OPTIMIS study, which is currently underway worldwide, and a large multicenter observational study on TACE could give further answers to our question. 33 Another limitation is that we could not evaluate the influence of the etiology of background liver disease. Hepatitis C has been almost conquered by direct-acting agents (DAAs).…”
Section: Ntermediate-stage or Bclc Stage B Hcc Consistsmentioning
confidence: 99%